

share
Fenharmane CAS NO 15301-68-5
Unit Price:
CAS No.:15301-68-5
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Fenharmane is a specialized organic compound with significant utility in advanced chemical synthesis and pharmaceutical research. Its unique structural properties make it a valuable intermediate for creating complex molecules with targeted biological or material functions. This product is essential for R&D laboratories and production facilities in the pharmaceutical, agrochemical, and fine chemical industries seeking reliable, high-purity building blocks.
Application
- Pharmaceutical Intermediate: Serves as a key building block in the synthesis of active pharmaceutical ingredients (APIs) and novel drug candidates.
- Agrochemical Synthesis: Used in the research and development of advanced pesticides, herbicides, and plant growth regulators.
- Fine Chemical Production: Acts as a precursor for dyes, pigments, and other performance chemicals requiring specific aromatic frameworks.
- Material Science Research: Employed in the development of organic electronic materials, ligands for catalysts, and specialty polymers.
- Academic & Industrial R&D: A valuable reagent for methodological studies in organic chemistry and process development.
Basic Information
| Product Name | Fenharmane |
| CAS No. | 15301-68-5 |
| Molecular Formula | C13H12N2 |
| Molecular Weight | 196.25 g/mol |
| Synonyms | 9H-Pyrido[3,4-b]indole, 1-Methyl-9H-pyrido[3,4-b]indole, Norharmane, 9H-β-Carboline, 1-Methyl-9H-β-carboline, β-Carboline-1-carboxylic acid (related derivative), NSC 163022 (historical identifier) |
| EINECS | Contact for details |
Quality Control
Our Fenharmane is manufactured under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for research and industrial use. A Certificate of Analysis (COA) detailing all test results is provided with every shipment.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white powder |
| Identification (IR) | Conforms to reference spectrum |
| Purity (HPLC) | ≥ 98.0% |
| Loss on Drying | ≤ 0.5% |
| Residue on Ignition | ≤ 0.1% |
| Heavy Metals (as Pb) | ≤ 20 ppm |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Tianeptine CAS NO 72797-41-2


Thozalinone CAS NO 655-05-0


Desipramine Hydrochloride CAS NO 58-28-6


Setiptiline CAS NO 57262-94-9


Agomelatine CAS NO 138112-76-2


Doxepin Hydrochloride CAS NO 1229-29-4


Protriptyline Hydrochloride CAS NO 1225-55-4


Clorgyline Hydrochloride CAS NO 17780-75-5


Tianeptine CAS NO 66981-73-5


Cimoxatone CAS NO 73815-11-9


Imipramine Hydrochloride CAS NO 113-52-0


Dothiepin CAS NO 113-53-1


Tranylcypromine CAS NO 155-09-9


Phenelzine Sulfate CAS NO 156-51-4


Northiaden CAS NO 1154-09-2


5-(3-Dimethylaminopropyl)-10,11-Dihydro-5H-Dibenzo[A,D]Cyclohepten-5-Ol CAS NO 1159-03-1


5-[3-(Dimethylamino)-2-Methylpropyl]-5H-Dibenz[B,F]Azepine Hydrochloride CAS NO 1159-80-4


Mefexamide Hydrochloride CAS NO 1227-61-8


3-Dibenzo[B,E]Thiepin-11(6H)-Ylidene-N,n-Dimethylpropylamine S-Oxide CAS NO 1447-71-8


Damotepine CAS NO 1469-07-4
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.





